Glottis, Amanta Healthcare receive Sebi nod to raise capital via IPO
Logistics firm Glottis and pharma company Amanta Healthcare have received Sebi's approval to launch IPOs. Glottis plans to raise up to Rs 160 crore via a fresh issue and an OFS of 1.45 crore shares. Amanta will issue 1.25 crore fresh equity shares. Both companies refiled their DRHPs earlier this year after previously withdrawing their IPO plans.
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Popular in Markets
Logistics services provider Glottis Limited and pharmaceutical firm Amanta Healthcare have received approval from the Securities and Exchange Board of India (Sebi) to raise capital through initial public offerings (IPOs), according to regulatory updates.Chennai-based Glottis, an integrated logistics firm focused on the energy supply chain, has secured SEBI's approval to launch its IPO. The offer comprises a fresh issue of equity shares worth up to Rs 160 crore and an offer for sale (OFS) of up to 1.45 crore equity shares by its promoters, as per the Draft Red Herring Prospectus (DRHP).Under the OFS, promoters Ramkumar Senthilvel and Kuttappan Manikandan will offload 72.5 lakh equity shares each.The company, which filed its draft papers with Sebi in February 2025, received its observation letter on June 16, 2025. In Sebi's terminology, an 'observation' indicates regulatory clearance to proceed with the IPO.Proceeds from the fresh issue will be utilised for capital expenditure towards the purchase of commercial vehicles and containers, and general corporate purposes.Glottis is a leading multimodal logistics service provider, specialising in end-to-end supply chain solutions for the energy sector. Its services span ocean and air freight forwarding, road transportation, warehousing, cargo handling, third-party logistics (3PL), and customs clearance. In FY24, the company handled 95,000 TEUs.For the fiscal year ended March 2024, Glottis reported revenue from operations of Rs 497 crore and a net profit of Rs 30.9 crore. In the first half of FY25, it posted revenue of Rs 436 crore and net profit of Rs 31.2 crore.Pantomath Capital Advisors Private Limited is acting as the sole book-running lead manager for the issue. The equity shares are proposed to be listed on both BSE and NSE.Pharmaceutical company Amanta Healthcare has also received the regulator's nod for its IPO, which will comprise a fresh issue of up to 1.25 crore equity shares, as outlined in the DRHP.The Ahmedabad-based company, promoted by Bhavesh Patel, initially filed IPO papers in September 2024 but withdrew them in January 2025 without disclosing a reason. It refiled the draft prospectus in February 2025.Founded in 1994, Amanta manufactures sterile liquid and parenteral products used when drugs cannot be administered orally. It also produces medical devices.Amanta currently holds 113 active product registrations with international regulatory authorities.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
22 minutes ago
- News18
‘Pinned Shawl, Tucked-In Shirts': Indian Company's Dress Code Screams Back To School
Last Updated: The post also included the screengrab of the offer letter rolled out by the company for the position of a developer with a monthly salary of Rs 12,000. A company has found itself in the spotlight for all the wrong reasons after enforcing a dress code that feels straight out of a school rulebook. According to a now-viral social media post, the organisation asked its employees to follow a rigid attire policy, including 'chudidhar suits with pinned shawls", 'tucked-in shirts", and 'neatly tied hair with ribbons." The detailed guidelines have drawn criticism online. Titled 'What even is this," the post was shared on Reddit with the caption, 'My friend got an offer letter, and we were going through it, and just wow. What does tucking in shirts or pinning a shawl even have to do with the work people do???" The post also included a screengrab of the offer letter rolled out by the company for the position of a developer with a monthly salary of Rs 12,000. The offer letter came with a section titled 'Dress Code and Grooming" that highlighted strict attire rules for men and women in the company. For men, formal wear and tucked-in shirts are mandated, with a ban on T-shirts. Jeans are permitted, but on a condition. They should be paired with a tucked-in shirt. 'Beard must be well-trimmed and groomed, 'it read. The company has stricter rules when it comes to women. They are only allowed to wear kurtas and churidars with shawls, which should be 'properly pinned." 'Strictly required to wear chudidar with properly pinned shawl. Loose/open hair is not allowed. Hair should be tied with a ribbon and maintained neatly. Attire must always be neat, modest, and appropriate," the policy for women read. As the post gained traction, social media users began comparing the rules to a strict dress code in schools. One user joked, 'Welcome back to school, guys. Also, they forgot to mention no running in the corridor and pin-drop silence." Another wrote, 'Why the h*ll don't they just ask women to wear formals if it's about 'professional' clothing? This isn't about professionalism, this is straight up misogyny." 'Which school is this? Are they taking mid-year admissions?" quipped another, stunned by the 'decorum' the company maintains. Earlier this year, an employee at a Pune-based company was fined Rs 100 for not wearing traditional attire during a Gudi Padwa celebration organised at the office. The incident came to light after the employee shared her experience on Reddit. She explained that, having just moved to a new city, she didn't own any traditional clothes and couldn't afford to buy any due to month-end financial constraints. Instead, she wore a white formal shirt and jeans. Despite her explanation, the HR department fined her for violating the dress code. The post went viral.
The Hindu
26 minutes ago
- The Hindu
Gland Pharma facility in Vizag recieves EIR from U.S. FDA
Gland Pharma's facility in Visakhapatnam, which was earlier this year issued Form 483 with three observations by the U.S. Food and Drug Administration, has since received an establishment inspection report from the agency, the generic injectable focussed company said on Tuesday, a development that saw its shares close 1.43% higher at ₹1,768.75 apiece on the BSE. The receipt of the EIR indicates closure of the U.S. FDA inspection conducted in February, the company said in a filling. A pre-approval inspection (PAI) for sterile active pharmaceutical ingredients (APIs), the U.S. FDA had inspected the facillity from February 19-25 and on conclusion issued a Form 483 with three observations. The company had then said the observations are procedural in nature and it will submit the corrective and preventive actions to the agency within the stipulated period. The observations issued are neither repeated observations nor related to data integrity, Gland Pharma had said.
Time of India
26 minutes ago
- Time of India
India's largest IT player is planning to open new offices in these cities
Tata Consultancy Services (TCS), India's largest IT services exporter, is planning to open new offices across multiple cities as part of a massive infrastructure and expansion push. As per a report by Economic Times' Sobia Khan , the company has earmarked over Rs 4,500 crore for setting up new campuses, leasing office space, and expanding its physical footprint nationwide. Cities on TCS's radar include Bengaluru, Kolkata, Hyderabad, Kochi, Coimbatore, and Visakhapatnam. In Bengaluru, TCS has made two major acquisitions—1.4–1.6 million sq ft from Sattva-Darshita for Rs 2,250 crore and 3.2 million sq ft from TRIL for Rs 1,625 crore. Together, these are expected to add 25,000 seats. Additionally, TCS leased 800,000 sq ft at 360 Degrees Business Park in Electronic City, further expanding its presence in India's tech capital. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy One, Get One Free, Up To 50% Discount, Expiring Soon Original Adidas Shop Now Undo In Kolkata, the company is developing 30 acres across its Sanchita Park and Bengal Silicon Valley Hub campuses, adding capacity for 16,500 seats—12,500 of which will be ready in 2025. TCS has also leased new office spaces in Coimbatore and Hyderabad, while in Visakhapatnam, the firm secured 21.6 acres on a 99-year lease from the government. In Kochi, it is acquiring 37 acres in the Kinfra Electronics Manufacturing Cluster for Rs 690 crore. Live Events According to industry experts, TCS's real estate moves point to a revival in the commercial office sector and confidence in India's talent ecosystem. The firm's investment in both metro and tier-2 cities suggests a long-term strategy to diversify and scale its delivery capabilities. Although TCS has not issued an official comment due to its silent period, its aggressive office expansion clearly signals preparation for future demand, return-to-office models, and hybrid workforce strategies. In April NASSCOM said that the Indian domestic tech market has maintained its growth momentum and has been growing faster than exports. "This growth is being driven by several tech companies that are focused on building in India for India, undertaking contracts for digital transformation of Indian enterprises and remain bullish about upcoming opportunities in the market," the industry association added.
